P2 purinoceptor antagonists inhibit the non-adrenergic, non-cholinergic relaxation of the human colon in vitro

Neuroscience

Volumn 147, Issue 1, 2007, Pages 146-152

  Benko R ^a   Undi, S ^a   Wolf, M ^a   Vereczkei, A ^a   Illenyi L ^a   Kassai, M ^a   Cseke, L ^a   Kelemen, D ^a   Horvath O P ^a   Antal, A ^b   Magyar, K ^a   Bartho L ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Department of Neurology and Stroke   (Hungary)

Author keywords

guanylate cyclase; human colon; NANC relaxation; nitric oxide; P2 purinoceptors

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ARGININE; ATROPINE; GUANETHIDINE; GUANYLATE CYCLASE INHIBITOR; NITRO LEVO ARGININE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; ADENOSINE TRIPHOSPHATE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DRUG DERIVATIVE; ENZYME INHIBITOR; GUANYLATE CYCLASE; N(G) NITROARGININE; NITRIC ACID; NITRIC OXIDE; OXADIAZOLE DERIVATIVE; PURINE P2 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID; QUINOXALINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTRIC FIELD; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NEUROTRANSMISSION; NONADRENERGIC NONCHOLINERGIC NERVE; PRIORITY JOURNAL; STIMULATION; DRUG ANTAGONISM; DRUG INTERACTION; ELECTROSTIMULATION; INNERVATION; METABOLISM; MUSCLE RELAXATION; MYENTERIC PLEXUS; NITRERGIC NERVE; NONPARAMETRIC TEST; PHYSIOLOGY; SIGMOID; SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; COLON, SIGMOID; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; GUANYLATE CYCLASE; HUMANS; MUSCLE RELAXATION; MUSCLE, SMOOTH; MYENTERIC PLEXUS; NEUROTRANSMITTER AGENTS; NITRERGIC NEURONS; NITRIC ACID; NITRIC OXIDE; NITROARGININE; OXADIAZOLES; PYRIDOXAL PHOSPHATE; QUINOXALINES; RECEPTORS, PURINERGIC P2; STATISTICS, NONPARAMETRIC; SURAMIN;

EID: 34249869850     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.04.016     Document Type: Article

References (50)

1. Barthó L., Lénárd Jr. L., and Szigeti R. Nitric oxide and ATP co-mediate the NANC relaxant response in the guinea-pig taenia caeci. Naunyn Schmiedebergs Arch Pharmacol 358 (1998) 496-499
2. Barthó L., Benkó R., Lázár Z., Illényi L., and Horváth Ö.P. Nitric oxide is involved in the relaxant effect of capsaicin in the human sigmoid colon circular muscle. Naunyn Schmiedebergs Arch Pharmacol 366 (2002) 496-500
3. Barthó L., Benkó R., Patacchini R., Pethõ G., Holzer-Petsche U., Holzer P., Lázár Z., Undi S., Illényi L., Antal A., and Horváth Ö.P. Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification. Eur J Pharmacol 500 (2004) 143-157
4. 2 purinoceptors account for the non-nitrergic NANC relaxation in the rat ileum. Naunyn Schmiedebergs Arch Pharmacol 373 (2006) 319-324 DOI 10.1007/s00210-006-0070-5
5. Boeckxstaens G.E., Pelckmans P.A., Herman A.G., and Van Maercke Y.M. Involvement of nitric oxide in the inhibitory innervation of the human isolated colon. Gastroenterology 104 (1993) 690-697
6. G-nitro-L-arginine reduces nonadrenergic, noncholinergic relaxations of human gut. Gastroenterology 102 (1992) 679-683
7. Burnstock G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36 (1997) 1127-1139
8. Chambers J.K., Macdonald L.E., Sarau H.M., Ames R.S., Freeman K., Foley J.J., Zhu Y., McLaughlin M.M., Murdock P., McMillan L., Trill J., Swift A., Aiyar N., Taylor P., Vawter L., Naheed S., Szekeres P., Hervieu G., Scott C., Watson J.M., Murphy A.J., Duzic E., Klein C., Bergsma D.J., Wilson S., and Livi G.P. A G protein-coupled receptor for UDP-glucose. J Biol Chem 275 (2000) 10767-10771
9. 4 receptor. Eur J Pharmacol 317 (1996) 383-389
10. Communi D., Parmentier M., and Boeynaems J.M. Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun 222 (1996) 303-308
11. Communi D., Govaerts C., Parmentier M., and Boeynaems J.M. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272 (1997) 31969-31973
12. 11 receptor. Br J Pharmacol 128 (1999) 1199-1206
13. Communi D., Gonzalez N.S., Detheux M., Brezillon S., Lannoy V., Parmentier M., and Boeynaems J.M. Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 276 (2001) 41479-41485
14. Dockray G.J. Physiology of enteric neuropeptides. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract. third edition (1994), Raven Press, New York 169-209
15. 2 purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol 93 (1988) 243-245
16. Facer P., Knowles C.H., Tam P.K., Ford A.P., Dyer N., Baecker P.A., and Anand P. Novel capsaicin (VR1) and purinergic (P2X3) receptors in Hirschsprung's intestine. J Pediatr Surg 36 (2001) 1679-1684
17. 1 receptors mediate inhibitory purinergic neuromuscular transmission in the human colon. Am J Physiol 291 (2006) G584-G594
18. Gever J.R., Cockayne D.A., Dillon M.P., Burnstock G., and Ford A.P. Pharmacology of P2X channels. Pflügers Arch 452 (2006) 513-537
19. Hartsfield C.L. Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal 4 (2002) 301-307
20. 2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol 99 (1990) 617-621
21. Huidobro-Toro J.P., and Yoshimura K. Pharmacological characterization of the inhibitory effects of neurotensin on the rabbit ileum myenteric plexus preparation. Br J Pharmacol 80 (1983) 645-653
22. Janssens R., Communi D., Pirotton S., Samson M., Parmentier M., and Boeynaems J.M. Cloning and tissue distribution of the human P2Y1 receptor. Biochem Biophys Res Commun 221 (1996) 588-593
23. Keef K.D., Du C., Ward S.M., McGregor B., and Sanders K.M. Enteric inhibitory neural regulation of human colonic circular muscle: role of nitric oxide. Gastroenterology 105 (1993) 1009-1016
24. + channels. Br J Pharmacol 119 (1996) 623-630
25. 2-purinoceptor mediated responses. Eur J Pharmacol 217 (1992) 217-219
26. Lecci A., Santicioli P., and Maggi C.A. Pharmacology of transmission to gastrointestinal muscle. Curr Opin Pharmacol 2 (2002) 630-641
27. Longhurst P.A., Schwegel T., Folander K., and Swanson R. The human P2X1 receptor: molecular cloning, tissue distribution, and localization to chromosome 17. Biochim Biophys Acta 1308 (1996) 185-188
28. G-nitro-L-arginine (l-NOARG) on non-adrenergic, non-cholinergic relaxation in the circular muscle of the human ileum. Br J Pharmacol 103 (1991) 1970-1972
29. Maggi C.A., and Giuliani S. Characterization of the apamin- and L-nitroarginine-resistant NANC inhibitory transmission to the circular muscle of guinea-pig colon. J Auton Pharmacol 16 (1996) 131-145
30. Maggi C.A., Patacchini R., Santicioli P., Giuliani S., Turini D., Barbanti G., Beneforti P., Misuri D., and Meli A. Human isolated small intestine: motor responses of the longitudinal muscle to field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol 339 (1989) 415-423
31. Martins S.L., De Oliveira R.B., and Ballejo G. Rat duodenum nitrergic-induced relaxations are cGMP-independent and apamin-sensitive. Eur J Pharmacol 284 (1995) 265-270
32. Morse D., Sethi J., and Choi A.M. Carbon monoxide-dependent signaling. Crit Care Med 30 (2002) S12-S17
33. Murr M.M., Balsiger B.M., Farrugia G., and Sarr M.G. Role of nitric oxide, vasoactive intestinal polypeptide, and ATP in inhibitory neurotransmission in human jejunum. J Surg Res 84 (1999) 8-12
34. Niioka S., Takeuchi T., Kishi M., Ishii T., Nishio H., Takewaki T., and Hata F. Nonadrenergic, noncholinergic relaxation in longitudinal muscle of rat jejunum. Jpn J Pharmacol 73 (1997) 155-161
35. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50 (1998) 413-492
36. 6 receptor. Eur J Pharmacol 329 (1997) 231-236
37. Said S.I., and Rattan S. The multiple mediators of neurogenic smooth muscle relaxation. Trends Endocrinol Metab 15 (2004) 189-191
38. Schmidt H.H.H.W. NO·, CO and ·OH, endogenous soluble guanylyl cyclase-activating factors. FEBS Lett 307 (1992) 102-107
39. Schwörer H., Katsoulis S., Creutzfeldt W., and Schmidt W.E. Pituitary adenylate cyclase activating peptide, a novel VIP-like gut-brain peptide, relaxes the guinea-pig taenia caeci via apamin-sensitive potassium channels. Naunyn Schmiedebergs Arch Pharmacol 346 (1992) 511-514
40. Smits G.J.M., and Lefebvre R.A. ATP and nitric oxide: inhibitory NANC neurotransmitters in the longitudinal muscle-myenteric plexus preparation of the rat ileum. Br J Pharmacol 118 (1996) 695-703
41. 1 receptor. Mol Pharmacol 60 (2001) 432-439
42. Tam F.S., and Hillier K. The role of nitric oxide in mediating non-adrenergic non-cholinergic relaxation in longitudinal muscle of human taenia coli. Life Sci 51 (1992) 1277-1284
43. Undi S., Benkó R., Wolf M., Illényi L., Horváth Ö.P., Antal A., Csontos Z., Vereczkei A., and Barthó L. Purinergic nerves mediate the non-nitrergic relaxation of the human ileum in response to electrical field stimulation. Brain Res Bull 71 (2006) 242-244
44. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110 (2005) 415-432
45. 2+ ions. Br J Pharmacol 140 (2003) 1177-1186
46. Xue L., Farrugia G., Sarr M.G., and Szurszewski J.H. ATP is a mediator of the fast inhibitory junction potential in human jejunal circular smooth muscle. Am J Physiol 276 (1999) G1373-G1379
47. Yamaji M., Ohta M., Yamazaki Y., Fujinami K., Fujita A., Takeuchi T., Hata F., and Takewaki T. A possible role of neurotensin in NANC relaxation of longitudinal muscle of the jejunum and ileum of Wistar rats. Br J Pharmacol 137 (2002) 629-636
48. Yiangou Y., Facer P., Baecker P.A., Ford A.P., Knowles C.H., Chan C.L., Williams N.S., and Anand P. ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease. Neurogastroenterol Motil 13 (2001) 365-369
49. Zagorodnyuk V., Santicioli P., Maggi C.A., and Giachetti A. The possible role of ATP and PACAP as mediators of apamin-sensitive NANC inhibitory junction potentials in circular muscle of guinea-pig colon. Br J Pharmacol 119 (1996) 779-786
50. Zhang F.L., Luo L., Gustafson E., Palmer K., Qiao X., Fan X., Yang S., Laz T.M., Bayne M., and Monsma Jr. F. P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 301 (2002) 705-713